Once-monthly dosing of oral ibandronate is at least as effective as daily dosing in postmenopausal osteoporosis: 1-year results from mobile

被引：0
|
作者：
Reginster, JY
Zikan, V
Lorenc, R
Hughes, C
Mairon, N
Bonvoisin, B
Stakkestad, JA
机构：
[1] Univ Liege, B-4000 Liege, Belgium
[2] Charles Univ, CR-11636 Prague, Czech Republic
[3] Childrens Mem Inst, Warsaw, Poland
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] CECOR AS, Haugesund, Norway
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S416 / S416
页数：1
相关论文
共 50 条
  • [1] Monthly oral ibandronate is at least as effective as oral daily ibandronate in postmenopausal osteoporosis: 1-Year results from MOBILE.
    Miller, PD
    Drezner, HK
    Delmas, PD
    Stakkestad, JA
    Hughes, C
    Bonvoisin, B
    Reginster, JY
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S94 - S94
  • [2] Once-monthly oral ibandronate is at least as effective as daily oral ibandronate in postmenopausal osteoporosis: 2-year findings from MOBILE.
    McClung, MR
    Drezner, MK
    Reginster, JY
    Bolognese, M
    Hughes, C
    Mairon, N
    Bonvoisin, B
    Delmas, PD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S395 - S395
  • [3] Once-monthly oral ibandronate (Boniva) dosing is highly efficacious in postmenopausal osteoporosis: 2-year results from MOBILE
    Silverman, S
    Greenwald, M
    Hawker, G
    Hughes, C
    Mairon, N
    Bonvoisin, B
    Reginster, JY
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S735 - S736
  • [4] Favorable safety profile of once-monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from mobile
    Nuti, R
    Stakkestad, JA
    Czerwinski, E
    Leigh, C
    Mairon, N
    Bonvoisin, B
    Cooper, C
    [J]. BONE, 2005, 36 : S418 - S419
  • [5] Monthly oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis: 1-year results from mobile
    Cooper, C
    Stepan, JJ
    Lorenc, R
    Hughes, C
    Mairon, N
    Sedarati, F
    Reginster, JY
    [J]. BONE, 2005, 36 : S417 - S417
  • [6] Monthly oral ibandronate is at least as effective as oral daily ibandronate: 1-Year results from MOBILE
    Emkey, R
    Hawker, G
    Greenwald, M
    Dumont, E
    Hughes, C
    Bonvoisin, B
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S670 - S670
  • [7] Upper gastrointestinal safety and tolerability profile of once-monthly and daily oral ibandronate is similar in postmenopausal osteoporosis:: 1-year results from mobile
    Adami, S
    Tankó, LB
    Nuti, R
    Leigh, C
    Mairon, N
    Sedarati, F
    Reginster, JY
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 364 - 364
  • [8] Once-monthly ibandronate for postmenopausal osteoporosis: Review of a new dosing regimen
    Pyon, Eunice Y.
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (04) : 475 - 490
  • [9] Once-monthly dosing of oral ibandronate is highly efficacious: 2-year results from mobile
    Reginster, J. -Y.
    Stakkestad, J. A.
    Lorenc, R.
    Hughes, C.
    Mairon, N.
    Coutant, K.
    Adami, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S64 - S65
  • [10] Once-monthly oral ibandronate - Effective treatment for postmenopausal osteoporosis (PMO): MOBILE 2-year results
    Miller, P
    Drezner, M
    Lewiecki, M
    Bolognese, M
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 803 - 803
12345